The Australian HCV Point-of-Care Testing Program

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults who have a risk factor for hepatitis C, or who use services for people with such risks. Participants have one visit for a finger-stick hepatitis C test and a survey.

Életkor

18 years and older

Nem

All sexes

Korábbi kezelés

People who had hepatitis C or hepatitis C treatment before can join. They get a different test (HCV RNA test).

A részvétel fő kizáró okai

• Unable or unwilling to give informed consent
• Unable or unwilling to follow the study requirements

A regiszter feltételei, szó szerint

Mit akar kideríteni a vizsgálat

The National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing services to people with a risk factor for the acquisition of HCV infection (including drug treatment clinics, needle and syringe programs, homelessness settings, mental health services, prisons, and mobile outreach). Participants will attend a single visit to have their HCV RNA status tested and complete a self-administered survey. Participants will not receive treatment as a part of this study. Participants who are HCV RNA positive will be linked to standard of care.

A vizsgálat csoportja

• People at risk of HCV acquisition

  This is an observational cohort study. Participants will be recruited from settings that provide services to people with a risk factor for the acquisition of HCV infection. Participants will attend a single visit to receive point-of-care HCV testing and complete a self-administered survey. Testing will be performed using point-of-care HCV antibody testing (results within 1-20 minutes, depending on the test) and if positive, HCV RNA testing will be performed. Participants who have previously had HCV infection or previously received HCV treatment will be tested using point-of-care HCV RNA testing. Participants will not receive treatment as a part of this study. Participants who are HCV RNA detectable will be linked to standard of care for any other clinical assessments and treatment initiation.

  Kezelés: Point-of-Care Testing